CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Sees Large Growth in Short Interest

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 190,400 shares, an increase of 2,438.7% from the October 31st total of 7,500 shares. Based on an average daily volume of 241,500 shares, the days-to-cover ratio is currently 0.8 days.

CNBX Pharmaceuticals Stock Performance

Shares of CNBX stock opened at $0.01 on Friday. CNBX Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.02. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.